Kala Bio (KALA) Return on Sales [ROS] (2019 - 2022)
Kala Bio's Return on Sales [ROS] came in at -2099.33% for Q4 2022, up 423.03 percentage points from -2522.36% a year earlier and up 1369.48 percentage points from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Return on Sales [ROS] (2019 - 2022) Analysis & Trends
Going back to Q1 2019, Kala Bio's Return on Sales [ROS] data covers 16 quarters.
- Return on Sales [ROS] carries a three-year change of -646.85 percentage points (FY2019 to FY2022).
- Going back by year, Return on Sales [ROS] was -1158.76% in FY2021 (+353.83 pp), -1512.59% in FY2020 (-60.10 pp) and -1452.49% in FY2019.
- The five-year range for quarterly Return on Sales [ROS] is -3468.81% (Q3 2022) to -850.05% (Q3 2021).
- Year-over-year, Return on Sales [ROS] increased in four of the last eight quarters, with an average year-over-year change of -270.66 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2021 (a gain of 1602.64 percentage points), and the weakest in Q3 2022 (a drop of 2618.76 percentage points).
- Business Quant data shows KALA's Return on Sales [ROS] at -3468.81% (Q3 2022), -1236.76% (Q2 2022) and -2253.21% (Q1 2022) in the three quarters before Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 32.98% |
| 10 | Kala Bio | 2.38 Mn | -42.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -2,099.33% |
| Sep 30, 2022 | -3,468.81% |
| Jun 30, 2022 | -1,236.76% |
| Mar 31, 2022 | -2,253.21% |
| Dec 31, 2021 | -2,522.36% |
| Sep 30, 2021 | -850.05% |
| Jun 30, 2021 | -951.98% |
| Mar 31, 2021 | -866.93% |
| Dec 31, 2020 | -1,295.08% |
| Sep 30, 2020 | -1,164.05% |
| Jun 30, 2020 | -2,554.62% |
| Mar 31, 2020 | -1,879.08% |
| Dec 31, 2019 | -1,711.61% |
| Sep 30, 2019 | -1,486.35% |
| Jun 30, 2019 | -1,089.45% |
| Mar 31, 2019 | -1,735.21% |
API Access
Kala Bio Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();